DUBENSKY, THOMAS, W., JR.,HOSKEN, NANCY, A.,ROBBINS, SCOTT, H.,MOORE, MARGARET, D.
申请号:
RSP20180792
公开号:
RS57420B1
申请日:
2013.05.16
申请国别(地区):
RS
年份:
2018
代理人:
摘要:
Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in either HSV-2 seropositive or seronegative subjects.